Canada markets open in 4 hours 32 minutes

Sosei Group Corporation (SOLTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
8.440.00 (0.00%)
At close: 11:05AM EDT

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • L
    Lauren
    - Dosing of first subject in clinical trial by Pfizer triggers $5 million payment to Sosei Heptares - Clinical development candidate is an oral, small molecule modulator of an undisclosed G protein-coupled receptor (GPCR) target TOKYO and LONDON, Dec. 23, 2019 /PR... Read this article on SOLTF https://marketwirenews.com/news-releases/sosei-heptares-announces-the-first-phase-i-clinical--6093181360989372.html?i=y
    - Dosing of first subject in clinical trial by Pfizer triggers $5 million payment to Sosei Heptares - Clinical development candidate is an oral,.
    - Dosing of first subject in clinical trial by Pfizer triggers $5 million payment to Sosei Heptares - Clinical development candidate is an oral,.
    marketwirenews.com